Loading…
pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery
•pH sensitive, mucoadhesive, N-succinyl chitosan graft polyacrylamide hydrogel preparation.•Good insulin encapsulation efficiency with pH sensitive sustained release.•Significant hypoglycemic effects in diabetic mice producing relative bioavailability of >4.4%.•No systemic toxicity at peroral adm...
Saved in:
Published in: | Carbohydrate polymers 2014-11, Vol.112, p.627-637 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •pH sensitive, mucoadhesive, N-succinyl chitosan graft polyacrylamide hydrogel preparation.•Good insulin encapsulation efficiency with pH sensitive sustained release.•Significant hypoglycemic effects in diabetic mice producing relative bioavailability of >4.4%.•No systemic toxicity at peroral administration.
pH sensitive PAA/S-chitosan hydrogel was prepared using ammonium persulfate (APS) as an initiator and methylenebisacrylamide (MBA) as a crosslinker for oral insulin delivery. The synthesized copolymer was characterized by Fourier transform infrared spectroscopy (FT-IR) and X-ray diffraction (XRD) study; morphology was observed under scanning electron microscope (SEM). The PAA/S-chitosan with ∼38% of insulin loading efficiency (LE) and ∼76% of insulin encapsulation efficiency (EE), showed excellent pH sensitivity, retaining ∼26% of encapsulated insulin in acidic stomach pH 1.2 and releasing of ∼98% of insulin in the intestine (pH 7.4), providing a prolonged attachment with the intestinal tissue. The oral administration of insulin loaded PAA/S-chitosan hydrogel was successful in lowering the blood glucose level of diabetic mice. The bioavailability of insulin was ∼4.43%. Furthermore, no lethality or toxicity was documented after its peroral administration. Thus, PAA/S-chitosan hydrogel could serve as a promising oral insulin carrier in future. |
---|---|
ISSN: | 0144-8617 1879-1344 |
DOI: | 10.1016/j.carbpol.2014.06.045 |